Article Text

Download PDFPDF
Highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @ShaneShapiroMD, @DrKimHarmon

  • Contributors We certify that the enclosed manuscript, entitled Highlights from the American Medical Society for Sports Medicine Position Statement on Responsible Use of Regenerative Medicine and Orthobiologics in Sports Medicine, represents original work and that we have reviewed the final version and approve it for publication. Neither this manuscript nor a manuscript with substantially similar content under our authorship has been published or is currently being considered for publication by any other publication. This manuscript will not be submitted to any other publication while it is under consideration by BJSM. We certify that all individuals listed as authors of this manuscript have participated in conceptualising the research or content of the manuscript, in writing or critically editing the manuscript, and/or in analysis of data presented in the manuscript. Each author will complete the ICMJE form to document competing interests related to the subject matter, materials, and products mentioned in this manuscript. A summary of potential competing interest are listed below.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests KM is a Consultant for Lipogems. GM receives Research support and an educational stipend from Lipogems. GM is a Board member of the Interventional Orthobiologic Foundation. JTF is a member of AMSSM Board of Directors, AAPM&R Board of Governors, and the Medical Advisory Board of Sanofi. JTF receives royalties from Demos Publishing and Up to Date. TMA is a consultant Consultant for Arthrex and Fujifilm Sonosite. TMA receives research funding from InGeneron, GID-BioMiMedx, Flexion Therepeutics, and Endo Pharmaceuticals. SAS is a consultant for Bioventus and on the BOD of the Biologic Association.

  • Provenance and peer review Not commissioned; externally peer reviewed.